Cargando…

Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients

PURPOSE: Assess the impact of viral load estimated by cycle threshold (Ct) of reverse transcription real time-polymerase chain reaction (rRT-PCR) and the days from symptoms onset on mortality in hospitalized patients with COVID19. METHODS: Retrospective observational study of 782 patients with a pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Rico-Caballero, Verónica, Fernández, Mariana, Hurtado, Juan C., Marcos, M. Angeles, Cardozo, Celia, Albiach, Laia, Agüero, Daiana, Ambrosioni, Juan, Bodro, Marta, Chumbita, Mariana, De la Mora, Lorena, Garcia-Pouton, Nicole, Gonzalez-Cordón, Ana, Dueñas, Gerard, Hernandez-Meneses, Marta, Inciarte, Alexy, Laguno, Montse, Leal, Lorna, Macaya, Irene, Martínez, Miguel J., Cuesta, Genoveva, Meira, Fernanda, Morata, Laura, Puerta-Alcalde, Pedro, Rojas, John, Torres, Berta, Castro, Pedro, Muñoz, Jose, Mensa, Josep, Martínez, José Antonio, Sanjuan, Gemma, Vila, Jordi, García, Felipe, Garcia-Vidal, Carolina, Soriano, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105593/
https://www.ncbi.nlm.nih.gov/pubmed/35562568
http://dx.doi.org/10.1007/s15010-022-01833-8
_version_ 1784708078383398912
author Rico-Caballero, Verónica
Fernández, Mariana
Hurtado, Juan C.
Marcos, M. Angeles
Cardozo, Celia
Albiach, Laia
Agüero, Daiana
Ambrosioni, Juan
Bodro, Marta
Chumbita, Mariana
De la Mora, Lorena
Garcia-Pouton, Nicole
Gonzalez-Cordón, Ana
Dueñas, Gerard
Hernandez-Meneses, Marta
Inciarte, Alexy
Laguno, Montse
Leal, Lorna
Macaya, Irene
Martínez, Miguel J.
Cuesta, Genoveva
Meira, Fernanda
Morata, Laura
Puerta-Alcalde, Pedro
Rojas, John
Torres, Berta
Castro, Pedro
Muñoz, Jose
Mensa, Josep
Martínez, José Antonio
Sanjuan, Gemma
Vila, Jordi
García, Felipe
Garcia-Vidal, Carolina
Soriano, Alex
author_facet Rico-Caballero, Verónica
Fernández, Mariana
Hurtado, Juan C.
Marcos, M. Angeles
Cardozo, Celia
Albiach, Laia
Agüero, Daiana
Ambrosioni, Juan
Bodro, Marta
Chumbita, Mariana
De la Mora, Lorena
Garcia-Pouton, Nicole
Gonzalez-Cordón, Ana
Dueñas, Gerard
Hernandez-Meneses, Marta
Inciarte, Alexy
Laguno, Montse
Leal, Lorna
Macaya, Irene
Martínez, Miguel J.
Cuesta, Genoveva
Meira, Fernanda
Morata, Laura
Puerta-Alcalde, Pedro
Rojas, John
Torres, Berta
Castro, Pedro
Muñoz, Jose
Mensa, Josep
Martínez, José Antonio
Sanjuan, Gemma
Vila, Jordi
García, Felipe
Garcia-Vidal, Carolina
Soriano, Alex
author_sort Rico-Caballero, Verónica
collection PubMed
description PURPOSE: Assess the impact of viral load estimated by cycle threshold (Ct) of reverse transcription real time-polymerase chain reaction (rRT-PCR) and the days from symptoms onset on mortality in hospitalized patients with COVID19. METHODS: Retrospective observational study of 782 patients with a positive rRT-PCR from a nasopharyngeal swab was performed within the first 24 h from admission. Demographic data, clinical manifestations and laboratory parameters were collected. Uni- and multivariate analyses were performed to identify factors associated with mortality at 60 days. RESULTS: Ct was divided into three groups and the mortality rate decreased from 27.3 to 20.7% and 9.8% for Ct values of ≤ 20, 21–25 and > 25, respectively (P = 0.0001). The multivariate analysis identified as predictors of mortality, a Ct value < 20 (OR 3.13, CI 95% 1.38–7.10), between 21–25 (OR 2.47, CI 95% 1.32–4.64) with respect to a Ct value > 25. Days from symptoms onset is a variable associated with mortality as well (DSOA) ≤ 6 (OR 1.86, CI 95% 1.00–3.46), among other factors. Patients requiring hospital admission within 6 DSOA with a Ct value ≤ 25 had the highest mortality rate (28%). CONCLUSIONS: The inclusion of Ct values and DSOA in the characterization of study populations could be a useful tool to evaluate the efficacy of antivirals.
format Online
Article
Text
id pubmed-9105593
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-91055932022-05-16 Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients Rico-Caballero, Verónica Fernández, Mariana Hurtado, Juan C. Marcos, M. Angeles Cardozo, Celia Albiach, Laia Agüero, Daiana Ambrosioni, Juan Bodro, Marta Chumbita, Mariana De la Mora, Lorena Garcia-Pouton, Nicole Gonzalez-Cordón, Ana Dueñas, Gerard Hernandez-Meneses, Marta Inciarte, Alexy Laguno, Montse Leal, Lorna Macaya, Irene Martínez, Miguel J. Cuesta, Genoveva Meira, Fernanda Morata, Laura Puerta-Alcalde, Pedro Rojas, John Torres, Berta Castro, Pedro Muñoz, Jose Mensa, Josep Martínez, José Antonio Sanjuan, Gemma Vila, Jordi García, Felipe Garcia-Vidal, Carolina Soriano, Alex Infection Original Paper PURPOSE: Assess the impact of viral load estimated by cycle threshold (Ct) of reverse transcription real time-polymerase chain reaction (rRT-PCR) and the days from symptoms onset on mortality in hospitalized patients with COVID19. METHODS: Retrospective observational study of 782 patients with a positive rRT-PCR from a nasopharyngeal swab was performed within the first 24 h from admission. Demographic data, clinical manifestations and laboratory parameters were collected. Uni- and multivariate analyses were performed to identify factors associated with mortality at 60 days. RESULTS: Ct was divided into three groups and the mortality rate decreased from 27.3 to 20.7% and 9.8% for Ct values of ≤ 20, 21–25 and > 25, respectively (P = 0.0001). The multivariate analysis identified as predictors of mortality, a Ct value < 20 (OR 3.13, CI 95% 1.38–7.10), between 21–25 (OR 2.47, CI 95% 1.32–4.64) with respect to a Ct value > 25. Days from symptoms onset is a variable associated with mortality as well (DSOA) ≤ 6 (OR 1.86, CI 95% 1.00–3.46), among other factors. Patients requiring hospital admission within 6 DSOA with a Ct value ≤ 25 had the highest mortality rate (28%). CONCLUSIONS: The inclusion of Ct values and DSOA in the characterization of study populations could be a useful tool to evaluate the efficacy of antivirals. Springer Berlin Heidelberg 2022-05-13 2022 /pmc/articles/PMC9105593/ /pubmed/35562568 http://dx.doi.org/10.1007/s15010-022-01833-8 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Paper
Rico-Caballero, Verónica
Fernández, Mariana
Hurtado, Juan C.
Marcos, M. Angeles
Cardozo, Celia
Albiach, Laia
Agüero, Daiana
Ambrosioni, Juan
Bodro, Marta
Chumbita, Mariana
De la Mora, Lorena
Garcia-Pouton, Nicole
Gonzalez-Cordón, Ana
Dueñas, Gerard
Hernandez-Meneses, Marta
Inciarte, Alexy
Laguno, Montse
Leal, Lorna
Macaya, Irene
Martínez, Miguel J.
Cuesta, Genoveva
Meira, Fernanda
Morata, Laura
Puerta-Alcalde, Pedro
Rojas, John
Torres, Berta
Castro, Pedro
Muñoz, Jose
Mensa, Josep
Martínez, José Antonio
Sanjuan, Gemma
Vila, Jordi
García, Felipe
Garcia-Vidal, Carolina
Soriano, Alex
Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients
title Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients
title_full Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients
title_fullStr Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients
title_full_unstemmed Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients
title_short Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients
title_sort impact of sars-cov-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized covid-19 patients
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105593/
https://www.ncbi.nlm.nih.gov/pubmed/35562568
http://dx.doi.org/10.1007/s15010-022-01833-8
work_keys_str_mv AT ricocaballeroveronica impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT fernandezmariana impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT hurtadojuanc impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT marcosmangeles impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT cardozocelia impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT albiachlaia impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT aguerodaiana impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT ambrosionijuan impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT bodromarta impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT chumbitamariana impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT delamoralorena impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT garciapoutonnicole impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT gonzalezcordonana impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT duenasgerard impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT hernandezmenesesmarta impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT inciartealexy impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT lagunomontse impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT leallorna impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT macayairene impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT martinezmiguelj impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT cuestagenoveva impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT meirafernanda impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT moratalaura impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT puertaalcaldepedro impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT rojasjohn impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT torresberta impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT castropedro impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT munozjose impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT mensajosep impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT martinezjoseantonio impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT sanjuangemma impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT vilajordi impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT garciafelipe impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT garciavidalcarolina impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT sorianoalex impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients
AT impactofsarscov2viralloadanddurationofsymptomsbeforehospitaladmissiononthemortalityofhospitalizedcovid19patients